Prosight Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,608
| Closed | -$33.6K | – | 51 |
|
|
2024
Q2 | $33.6K | Sell |
5,608
-90,752
| -94% | -$545K | 0.01% | 46 |
|
|
2024
Q1 | $869K | Sell |
96,360
-240,173
| -71% | -$2.17M | 0.24% | 41 |
|
|
2023
Q4 | $3.19M | Sell |
336,533
-140,547
| -29% | -$1.33M | 1.28% | 18 |
|
|
2023
Q3 | $5.68M | Buy |
477,080
+11,888
| +3% | +$141K | 1.8% | 19 |
|
|
2023
Q2 | $11.4M | Buy |
465,192
+145,192
| +45% | +$3.56M | 3.34% | 13 |
|
|
2023
Q1 | $10M | Buy |
320,000
+144,557
| +82% | +$4.52M | 4.75% | 6 |
|
|
2022
Q4 | $12.4M | Buy |
175,443
+42,653
| +32% | +$3M | 6.74% | 3 |
|
|
2022
Q3 | $11.4M | Buy |
132,790
+6,521
| +5% | +$561K | 6.13% | 4 |
|
|
2022
Q2 | $10.4M | Buy |
126,269
+96,269
| +321% | +$7.96M | 8.23% | 3 |
|
|
2022
Q1 | $4.99M | Sell |
30,000
-6,000
| -17% | -$997K | 3.22% | 9 |
|
|
2021
Q4 | $6.02M | Sell |
36,000
-26,996
| -43% | -$4.51M | 3.6% | 8 |
|
|
2021
Q3 | $5.44M | Sell |
62,996
-39,374
| -38% | -$3.4M | 2.99% | 11 |
|
|
2021
Q2 | $5.56M | Buy |
102,370
+27,339
| +36% | +$1.48M | 3.48% | 8 |
|
|
2021
Q1 | $4.47M | Buy |
+75,031
| New | +$4.47M | 3.66% | 11 |
|
|
2020
Q4 | – | Sell |
-36,598
| Closed | -$1.77M | – | 45 |
|
|
2020
Q3 | $1.77M | Buy |
+36,598
| New | +$1.77M | 0.84% | 30 |
|
|
2020
Q2 | – | Sell |
-9,662
| Closed | -$421K | – | 52 |
|
|
2020
Q1 | $421K | Sell |
9,662
-22,338
| -70% | -$973K | 0.2% | 39 |
|
|
2019
Q4 | $1.28M | Buy |
+32,000
| New | +$1.28M | 0.56% | 31 |
|
|
2019
Q3 | – | Sell |
-3,422
| Closed | -$264K | – | 40 |
|
|
2019
Q2 | $264K | Buy |
+3,422
| New | +$264K | 0.13% | 37 |
|
|
2018
Q4 | – | Sell |
-5,233
| Closed | -$1.12M | – | 36 |
|
|
2018
Q3 | $1.12M | Buy |
5,233
+1,064
| +26% | +$228K | 0.62% | 28 |
|
|
2018
Q2 | $721K | Buy |
+4,169
| New | +$721K | 0.53% | 26 |
|